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Non-standard Abbreviations and Acronyms:  
LV: Left Ventricle 
MI: Myocardial Infarction  
MINOCA: Myocardial Infarction with Non-Obstructed Coronary Arteries 
NOA: Non-obstructive Atherosclerosis 
RV: Right Ventricle 
SCD: Sudden Cardiac Death 
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Myocardial infarction with non-obstructed coronary arteries (MINOCA) accounts for 1-10% 
of all causes of acute myocardial infarction (MI) and may be secondary to various specific 
aetiologies with implications for prognosis1. The aim of the study was to describe the clinical 
and pathological features of a cohort of decedents of sudden cardiac death (SCD) attributable 
to MINOCA at autopsy.  
MINOCA was defined as evidence of acute MI and/or acute coronary thrombosis in the 
absence of epicardial coronary artery stenosis ≥50%1,2. The data that support the findings of 
this study are available from the corresponding author upon reasonable request. 
We reviewed a database of 5325 consecutive cases of SCD referred to our specialist cardiac 
pathology center between 1994 and July 2017. SCD was defined as death from a 
cardiovascular cause within 12 hours of apparent well-being. Clinical information was 
obtained from referring coroners who were asked to complete a questionnaire inquiring about 
the demographic characteristics of the decedent, medical history, family history and 
circumstances of death. All cases underwent detailed autopsy evaluation of the heart, 
including histological analysis, by expert cardiac pathologists3. A minimum of 10 blocks of 
tissue were taken for histological analysis. The origin of each artery was identified and a 
probe with a diameter of 2mm inserted in the coronary ostia to assess the presence of 
stenosis. The vessels were then dissected and examined with transverse cuts each 2mm 
throughout their whole length.At least 10 sections (average 13) of myocardium were then 
taken and stained with haematoxylin and eosin as well as elastic Van Gieson stain. 
Exclusion criteria included specific cardiac conditions as previously reported4, including 
myocarditis and Tako-Tsubo cardiomyopathy, which were ruled-out by clinical records 
examination3 and through histology3,4 . Non-obstructive atherosclerosis (NOA) was defined 
4 
by the presence of atheroma in any coronary section resulting in coronary stenosis <50%.  
Ethical and research governance approval have been granted for this study (10/H0724/38). 
The next of kin consented to material retention for anonymized research in each case. 
We identified 37 (0.7%) cases of MINOCA. The majority of decedents were male (n=23; 
62%). Mean age at death was 34±16 years (range 13-96 years), and 6 individuals were <18 
years of age (Figure 1). Cardiac symptoms were reported in 18 cases (49%): chest pain 
(n=12; 32%), dyspnoea (n =6; 16%), syncope (n=2; 5%) and palpitations (n=1; 3%). None of 
decedents had a pre-mortem diagnosis of ischemic cardiac disease. Death occurred at rest or 
during daily activities in 36 (97%) individuals, including 9 (24%) who died during sleep. 
According to the information available, 2 decedents were reported to be currently smokers, 1 
was ex-smoker and 3 were reported as “never smoked”.Drug use was reported in 10 (27%) 
including marijuana in 3 (8%), cocaine in 2 (5%), heroin in 2 (5%), methadone in 2 (5%), 
anabolic steroids in 2 (5%), amphetamine in 1 (3%) cases. Of the 10 cases, toxicology testing 
showed the presence of the same substance in 30% at non-toxic levels. The coronary 
dominance was right in 36, co-dominant in 1. NOA was found in 13 patients (35%). 
Coronary thrombosis was found in 9 out of 13 (69%) patients with NOA and the mechanism 
of thrombosis was plaque erosion in 7 (78%) and fissuring in 2 (22%). The MI age was 24-
48 hours in 28 cases (76%) and 1-6 weeks in the rest of decedents. The MI histological 
changes were found at the level of the left ventricular (LV) anteroseptal wall in 14 (38%) 
individuals, the LV and right ventricular (RV) subendocardial wall in 9, the LV postero-basal 
wall in 6, the RV and LV diffusely in 5, the LV lateral wall in 2 cases; in 1 case the MI 
involved exclusively the right atrium leading to atrial wall rupture and subsequent cardiac 
tamponade. In a minority (n=9; 24%) LV fibrosis was detected in a myocardial territory that 
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was different from the one of the MI, with a subendocardial distribution in 3 cases and near 
transmural (75% of the myocardial wall) in 1. 
Our study reports on the largest autopsy cohorts of individuals with SCD due to MINOCA in 
which the post-mortem was performed by an expert cardiac pathologist following a 
standardized protocol. Most deaths occurred at rest, although almost half of the decedents 
reported cardiac symptoms. Toxicology analysis was positive in one out of three victims with 
background of drug use, thus representing a possible aetiological mechanism for both 
MINOCA and SCD. Ischaemic damage had a diffuse or regional pattern with the 
anteroseptal wall most often involved. In a minority, replacement fibrosis with an ischemic 
pattern was identified in a territory that was different from the one of the acute MI, implying 
that subclinical MI may have occurred before SCD, representing a substrate for arrhythmias. 
Of interest, coronary thrombus was exclusively found among patients with NOA, whereas 
among patients with no macroscopic evidence of atherosclerotic plaque coronary spasm 
possibly played a role. Our study has some limitations. It is possible that we may have 
underestimated the proportion of individuals with MINOCA who presented with SCD as the 
first manifestation because local pathologists may not have referred decedents with an 
established pre-mortem diagnosis of MI to our center. However, our center receives a high 
volume of referrals (>500 SCD cases per year - mostly young decedents); furthermore, MI 
with normal coronary arteries is likely to be considered an uncertain finding by a non-expert 
cardiac pathologist and therefore referred to for our assessment. The lack of 
electrocardiogram in decedents of SCD is also a limitation. Moreover, although MINOCA 
was originally a pathological definition, to date it remains a clinical diagnosis and post-
mortem pathological examination can confirm or exclude the presence of an anatomical 
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substrate of MI5. In conclusion, MINOCA is an uncommon cause of SCD which usually 
occurs in young individuals, often at rest or during daily activities and cardiac symptoms are 
reported in almost half of the cases. The high proportion of decedents reporting use of drugs 
and anabolic steroids underscores a possible mechanistic link with MINOCA and SCD 
especially in young individuals. 
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Figure legend 
Figure 1. Sudden cardiac death in patients with MINOCA. 
LV, left ventricle; MI, myocardial infarction; MINOCA, myocardial infarction with non-
obstructed coronary arteries. 

